Panacea Index Logo

Command Palette

Search for a command to run...

Iron supplementation decreases plasma zinc but has no effect on plasma fatty acids in non-anemic women.

Nutrition research (New York, N.Y.)
April 1, 2013
Kamrul Zaman et al. (7 authors)
Journal ArticleRandomized Controlled TrialResearch Support, Non-U.S. Gov'tHuman StudyClinical
Study Details

Study Goal

The researchers aimed to determine the effect of iron supplementation on fatty acid desaturase activity in young women.

Results Summary

Iron supplementation improved iron status but had no significant effect on desaturase activity. A decrease in plasma zinc concentrations was observed in the supplemented group, suggesting an antagonistic interaction between iron and zinc.

Population

Young women (mean age ~25 years, BMI ~21.5 kg/m²)

Effective Dosage

37.4 mg of elemental iron daily

Duration

12 weeks

Interactions

Antagonism between iron and zinc noted (decreased plasma zinc concentrations in supplemented group)

Extracted Claims (9)
InterventionDirectionEndpointPopulationDosageImpactClaim #
iron supplementation
increase
serum ferritin concentrations
subjects assigned to SG
-
increased significantly
#1
iron supplementation
no change
serum ferritin concentrations
CG
-
were unchanged
#2
iron supplementation
no change
serum iron concentrations
-
-
were not significantly changed
#3
iron supplementation
decrease
plasma zinc concentrations
SG
-
were decreased significantly
#4
iron supplementation
no change
plasma zinc concentrations
CG
-
were similar to baseline values
#5
iron supplementation
no change
plasma fatty acids, phospholipid fatty acids, and desaturase activities
-
-
were not significantly affected
#6
iron supplementation
increase
Δ6-desaturase activity
SG
-
was correlated positively
#7
low dose iron
increase
iron status
non-anemic women
-
improves
#8
low dose iron
no change
desaturase activity
non-anemic women
-
has no significant effect
#9
Abstract

Limited information is available on the role of iron in fatty acid metabolism in humans. We hypothesized that iron supplementation will increase desaturase activity, and so, the aim of this study was to determine the effect of iron supplementation on fatty acid desaturase activity in young women. Participants were randomly assigned to a control group (CG) or supplementation group (SG) who were provided with 37.4 mg of elemental iron daily for 12 weeks. Forty women completed the trial, n = 19 in CG and n = 21 in SG. The mean ages were 25.2 and 24.6 years, and body mass indices were 21.8 and 21.2 (kg/m(2)) in CG and SG, respectively. Serum ferritin concentrations increased significantly (P < .01) in subjects assigned to SG but were unchanged in CG. Serum iron concentrations were not significantly changed. Plasma zinc concentrations at the end of the intervention were similar to baseline values for individuals in CG but were decreased significantly (P = .004) in SG. Plasma fatty acids, phospholipid fatty acids, and desaturase activities, expressed as precursor-to-product ratios, were not significantly affected by the intervention, although in SG the concentration of serum ferritin was correlated positively (P < .05) with Δ6-desaturase activity. Supplementing non-anemic women with low dose iron improves iron status but has no significant effect on desaturase activity. The lack of a clear effect on an indirect indicator of desaturase activity may be related to the antagonism between iron and zinc, as illustrated by the decrease in plasma zinc concentrations in women who were supplemented with iron.

Medical Subject Headings (MeSH)
AdolescentAdultAnemiaDietary SupplementsFatty Acid DesaturasesFatty AcidsFemaleFerritinsHealthy VolunteersHumansIron, DietaryNutritional StatusYoung AdultZinc
Study Links
Quality Scores
Safety85
Efficacy30/10
Quality75/10
Citation Metrics
Total Citations5
Citations/Year0.4
Relative Citation Ratio0.25
NIH Percentile13%
Research Impact Scores
APT Score0.25
Weight Score1.32
Normalized Score0.61
Related Supplements